Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 10, 2007, Pages 3485-3490

  Dahl, Erica L ^a   Rosenthal, Philip J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CHLOROQUINE; CIPROFLOXACIN; CLINDAMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXYCYCLINE; RIFAMPICIN;

ANTIMALARIAL ACTIVITY; APICOPLAST; ARTICLE; CELL DIVISION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME INHIBITION; ERYTHROCYTE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROGENY; PROTEIN SYNTHESIS INHIBITION; SCHIZONT;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMALARIALS; DNA GYRASE; DRUG RESISTANCE; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; PLASMODIUM FALCIPARUM; PROTEIN SYNTHESIS INHIBITORS;

EID: 34948847580     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00527-07     Document Type: Article

References (49)

1. Baird, J. K. 2005. Effectiveness of antimalarial drugs. N. Engl. J. Med. 352:1565-1577.
2. Baudon, D., G. Martet, B. Pascal, J. Bernard, A. Keundjian, and R. Laroche. 1999. Efficacy of daily antimalarial chemoprophylaxis in tropical Africa using either doxycycline or chloroquine-proguanil: a study conducted in 1996 in the French Army. Trans. R. Soc. Trop. Med. Hyg. 93:302-303.
3. Beckers, C. J., D. S. Roos, R. G. Donald, B. J. Luft, J. C. Schwab, Y. Cao, and K. A. Joiner. 1995. Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics. J. Clin. Investig. 95:367-376.
4. Begg, E. J., R. A. Robson, D. A. Saunders, G. G. Graham, R. C. Buttimore, A. M. Neill, and G. I. Town. 2000. The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing. Br. J. Clin. Pharmacol. 49:32-38.
5. Borrmann, S., S. Issifou, G. Esser, A. A. Adegnika, M. Ramharter, P. B. Matsiegui, S. Oyakhirome, D. P. Mawili-Mboumba, M. A. Missinou, J. F. Kun, H. Jomaa, and P. G. Kremsner. 2004. Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria. J. Infect. Dis. 190:1534-1540.
6. Bremen, J. G. 2001. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am. J. Trop. Med. Hyg. 64(Suppl. 1-2):1-11.
7. Camps, M., G. Arrizabalaga, and J. Boothroyd. 2002. An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii. Mol. Microbiol. 43:1309-1318.
8. Chaubey, S., A. Kumar, D. Singh, and S. Habib. 2005. The apicoplast of Plasmodium falciparum is translationally active. Mol. Microbiol. 56:81-89.
9. Clough, B., M. Strath, P. Preiser, P. Denny, and I. R. Wilson. 1997. Thiostrepton binds to malarial plastid rRNA. FEBS Lett. 406:123-125.
10. Clough, B., and I. R. Wilson. 2001. Antibiotics and the plasmodial plastid organelle, p. xi. In P. J. Rosenthal (ed.), Antimalarial chemotherapy: mechanisms of action, resistance, and new directions in drug discovery. Humana Press, Totowa, NY.
11. Cook, J. A., E. J. Randinitis, C. R. Bramson, and D. L. Wesche. 2006. Lack of a pharmacokinetic interaction between azithromycin and chloroquine. Am. J. Trop. Med. Hyg. 74:407-412.
12. Dahl, E. L., J. L. Shock, B. R. Shenai, J. Gut, J. L. DeRisi, and P. J. Rosenthal. 2006. Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum. Antimicrob. Agents Chemother. 50: 3124-3131.
13. Divo, A. A., T. G. Geary, and J. B. Jensen. 1985. Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in culture. Antimicrob. Agents Chemother. 27:21-27.
14. Dunne, M. W., N. Singh, M. Shukla, N. Valecha, P. C. Bhattacharyya, V. Dev, K. Patel, M. K. Mohapatra, J. Lakhani, R. Benner, C. Lele, and K. Patki. 2005. A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. J. Infect. Dis. 191:1582-1588.
15. Fichera, M. E., M. K. Bhopale, and D. S. Roos. 1995. In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii. Antimicrob. Agents Chemother. 39:1530-1537.
16. Fichera, M. E., and D. S. Roos. 1997. A plastid organelle as a drug target in apicomplexan parasites. Nature 390:407-409.
17. Foth, B. J., S. A. Ralph, C. J. Tonkin, N. S. Struck, M. Fraunholz, D. S. Roos, A. F. Cowman, and G. I. McFadden. 2003. Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum. Science 299:705-708.
18. Gardner, M. J., N. Hall, E. Fung, O. White, M. Berriman, R. W. Hyman, J. M. Carlton, A. Pain, K. E. Nelson, S. Bowman, I. T. Paulsen, K. James, J. A. Eisen, K. Rutherford, S. L. Salzberg, A. Craig, S. Kyes, M. S. Chan, V. Nene, S. J. Shallom, B. Suh, J. Peterson, S. Angiuoli, M. Pertea, J. Allen, J. Selengut, D. Haft, M. W. Mather, A. B. Vaidya, D. M. Martin, A. H. Fairlamb, M. J. Fraunholz, D. S. Roos, S. A. Ralph, G. I. McFadden, L. M. Cummings, G. M. Subramanian, C. Mungall, J. C. Venter, D. J. Carucci, S. L. Hoffman, C. Newbold, R. W. Davis, C. M. Fraser, and B. Barrell. 2002. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419:498-511.
19. Geary, T. G., and J. B. Jensen. 1983. Effects of antibiotics on Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 32:221-225.
20. Goodman, C. D., V. Su, and G. I. McFadden. 2007. The effects of antibacterials on the malaria parasite Plasmodium falciparum. Mol. Biochem. Parasitol. 152:181-191.
21. He, C. Y., M. K. Shaw, C. H. Pletcher, B. Striepen, L. G. Tilney, and D. S. Roos. 2001. A plastid segregation defect in the protozoan parasite Toxoplasma gondii. EMBO J. 20:330-339.
22. Kiatfuengfoo, R., T. Suthiphongchai, P. Prapunwattana, and Y. Yuthavong. 1989. Mitochondria as the site of action of tetracycline on Plasmodium falciparum. Mol. Biochem. Parasitol. 34:109-115.
23. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
24. Lell, B., and P. G. Kremsner. 2002. Clindamycin as an antimalarial drug: review of clinical trials. Antimicrob. Agents Chemother. 46:2315-2320.
25. Lin, Q., K. Katakura, and M. Suzuki. 2002. Inhibition of mitochondrial and plastid activity of Plasmodium falciparum by minocycline. FEBS Lett. 515: 71-74.
26. McConkey, G. A., M. J. Rogers, and T. F. McCutchan. 1997. Inhibition of Plasmodium falciparum protein synthesis. Targeting the plastid-like organelle with thiostrepton. J. Biol. Chem. 272:2046-2049.
27. Miller, R. S., C. Wongsrichanalai, N. Buathong, P. McDaniel, D. S. Walsh, C. Knirsch, and C. Ohrt. 2006. Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study. Am. J. Trop. Med. Hyg. 74:401-406.
28. Na-Bangchang, K., R. Ruengweerayut, J. Karbwang, A. Chauemung, and D. Hutchinson. 2007. Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malaria. Malaria J. 6:70.
29. Newton, P. N., J. F. Chaulet, A. Brockman, W. Chierakul, A. Dondorp, R. Ruangveerayuth, S. Looareesuwan, C. Mounier, and N. J. White. 2005. Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria. Antimicrob. Agents Chemother. 49:1622-1625.
30. Noedl, H., S. Krudsood, K. Chalermratana, U. Silachamroon, W. Leowattana, N. Tangpukdee, S. Looareesuwan, R. S. Miller, M. Fukuda, K. Jongsakul, S. Sriwichai, J. Rowan, H. Bhattacharyya, C. Ohrt, and C. Knirsch. 2006. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. Clin. Infect. Dis. 43:1264-1271.
31. Noedl, H., S. Krudsood, W. Leowattana, N. Tangpukdee, W. Thanachartwet, S. Looareesuwan, R. S. Miller, M. Fukuda, K. Jongsakul, K. Yingyuen, S. Sriwichai, C. Ohrt, and C. Knirsch. 2007. In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. Antimicrob. Agents Chemother. 51:651-656.
32. Pradines, B., C. Regier, T. Fusai, J. Mosnier, W. Daries, E. Barret, and D. Parzy. 2001. In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron. Antimicrob. Agents Chemother. 45:1746-1750.
33. Ralph, S. A., G. G. Van Dooren, R. F. Waller, M. J. Crawford, M. J. Fraunholz, B. J. Foth, C. J. Tonkin, D. S. Roos, and G. I. McFadden. 2004. Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat. Rev. Microbiol. 2:203-216.
34. Ramya, T. N., K. Karmodiya, A. Surolia, and N. Surolia. 2007. 15-Deoxyspergualin primarily targets the trafficking of apicoplast proteins in Plasmodium falciparum. J. Biol. Chem. 282:6388-6397.
35. Ramya, T. N., S. Mishra, K. Karmodiya, N. Surolia, and A. Surolia. 2007. Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum. Antimicrob. Agents Chemother. 51:307-316.
36. Seaberg, L. S., A. R. Parquette, I. Y. Gluzman, G. W. Phillips, Jr., T. F. Brodasky, and D. J. Krogstad. 1984. Clindamycin activity against chloroquine-resistant Plasmodium falciparum. J. Infect. Dis. 150:904-911.
37. Sidhu, A. B., Q. Sun, L. J. Nkrumah, M. W. Dunne, J. C. Sacchettini, and D. A. Fidock. 2007. In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin. J. Biol. Chem. 282:2494-2504.
38. Snow, R. W., C. A. Guerra, A. M. Noor, H. Y. Myint, and S. I. Hay. 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:214-217.
39. Taylor, W. R., H. Widjaja, T. L. Richie, H. Basri, C. Ohrt, Tjitra, E. Taufik, T. R. Jones, K. C. Kain, and S. L. Hoffman. 2001. Chloroquine/doxycycline combination versus chloroquine alone, and doxycycline alone for the treatment of Plasmodium falciparum and Plasmodium vivax malaria in northeastern Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 64:223-228.
40. Thummel, K. E., and D. D. Shen. 2001. Design and optimization of dosage regimens: pharmacokinetic data, p. 1917-2023. In J. G. Hardman, L. E. Limbird, and A. G. Gilman (ed.), Goodman & Gilman's the pharmacological basis of therapeutics, 10th ed. McGraw-Hill, New York, NY.
41. Trager, W., and J. B. Jenson. 1978. Cultivation of malarial parasites. Nature 273:621-622.
42. Waller, R. F., and G. I. McFadden. 2005. The apicoplast: a review of the derived plastid of apicomplexan parasites. Curr. Issues Mol. Biol. 7:57-79.
43. Waller, R. F., M. B. Reed, A. F. Cowman, and G. I. McFadden. 2000. Protein trafficking to the plastid of Plasmodium falciparum is via the secretory pathway. EMBO J. 19:1794-1802.
44. Weissig, V., T. S. Vetro-Widenhouse, and T. C. Rowe. 1997. Topoisomerase II inhibitors induce cleavage of nuclear and 35-kb plastid DNAs in the malarial parasite Plasmodium falciparum. DNA Cell Biol 16:1483-1492.
45. Williamson, D. H., P. R. Preiser, P. W. Moore, S. McCready, M. Strath, and R. J. Wilson. 2082. The plastid DNA of the malaria parasite Plasmodium falciparum is replicated by two mechanisms. Mol. Microbiol. 45:533-542.
46. Wilson, R. J. 2005. Parasite plastids: approaching the endgame. Biol. Rev. Camb. Philos. Soc. 80:129-153.
47. Wilson, R. J., P. W. Denny, P. R. Preiser, K. Rangachari, K. Roberts, A. Roy, A. Whyte, M. Strath, D. J. Moore, P. W. Moore, and D. H. Williamson. 1996. Complete gene map of the plastid-like DNA of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 261:155-172.
48. Yeo, A. E., and K. H. Rieckmann. 1995. Increased antimalarial activity of azithromycin during prolonged exposure of Plasmodium falciparum in vitro. Int. J. Parasitol. 25:531-532.
49. Zuegge, J., S. Ralph, M. Schmuker, G. I. McFadden, and G. Schneider. 2001. Deciphering apicoplast targeting signals-feature extraction from nuclear-encoded precursors of Plasmodium falciparum apicoplast proteins. Gene 280:19-26.